Detection and characterization of placental microRNAs in maternal plasma.
By S. S. Chim, Tristan K F Shing, E. C. Hung, T. Leung, T. Lau, R. Chiu, Y. Dennis Lo. Clinical Chemistry, 2008
851 citations recorded by the source corpus.
Subfields: Cancer Research, Immunology, Obstetrics and Gynecology
View Paper: https://www.semanticscholar.org/paper/a024c275f66cca3cd025d986c919fd6387c0d447
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Carlo Maria Croce
- H. Alder
- E. J. Lee
- Thomas D. Schmittgen
- George A. Calin
- Marilena V. Iorio
- Manel Esteller
In Immunology
In Obstetrics and Gynecology
Citations in the corpus
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. (2009, background): “Placental-associated circulating miRNAs correlate with pregnancy progression [15].”
- MicroRNAs in body fluids—the mix of hormones and biomarkers (2011, neutral): “It was demonstrated that the cell-free miRNAs were probably derived from normal and/or tumor-lysed cells in body fluids”
- Circulating microRNAs as stable blood-based markers for cancer detection (2008, background): “(22) reported the detection by qRT-PCR of miRNAs of presumed placental origin in the plasma of pregnant women, and Lawrie et al.”
- Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection (2009, background): “This study also showed that endogenous plasma miRNAs are more stable than exogenous miRNAs (31).”
- Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies (2011, background): “Since the initial description of circulating miRNAs in 2008 (1-4), over 200 papers have reported circulating miRNAs as biomarkers for detection of a range of cancer types and other diseases (5, 6).”
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening (2009, background): “Furthermore, miRNA markers have several advantages: (1) unlike screening for large numbers of mRNA expression, a modest number of miRNAs might be sufficient to differentiate cancers from normal; and (2) unlike plasma mRNAs, miRNAs in plasma remain largely intact and have been proven to be more stabl”
- Detection of microRNA Expression in Human Peripheral Blood Microvesicles (2008, background): “While it has been reported that miRNAs are detected in the plasma [41,42,61–63], this is the first study to profile miRNAs from the plasma microvesicles in a normal healthy population.”
- Serum MicroRNAs Are Promising Novel Biomarkers (2008, background): “While this manuscript was in preparation, it was reported that microRNAs are detectable in serum [19].”